RealPharma: Conversations with Pharma Pathfinders

Healthcare Leadership and Resilience with Grace Magedman

In this powerful and deeply human episode of RealPharma, we’re joined by Grace Magedman, PharmD—former Chief Pharmacy Officer at Children’s Hospital of Orange County, functional medicine practitioner, and founder of The Magidman Group.Grace takes us inside her 20+ years of hospital pharmacy leadership, where she navigated high-stakes medication decisions, complex implementation of rare disease therapies, and the ethical strain of resource constraints. But her most transformative leadership moment came not in the boardroom—but in her own experience of burnout.Now a certified high-performance coach, Grace shares how she rebuilt from the inside out, creating the Functional Resilience Framework—a science-based system that blends neuroscience, functional medicine, and leadership development to help others sustain performance without sacrificing purpose.Whether you’re in pharma, hospital leadership, or simply navigating the demands of high-impact work, Grace’s insights offer a roadmap to lead with clarity, energy, and longevity.📌 Resources & Links:Learn more about Grace’s work: magedmangroup.comConnect with Grace on LinkedIn: linkedin.com/in/magedman/Interested in the Functional Resilience Framework? Contact Grace directly for coaching or workshops.

Bridging the Gap in Cancer Care Part 2: Dr. Yaming Wang on Innovation, Access, and the Power of Knowledge

In this second part of our deep dive into hematology and oncology, we welcome back Dr. Yaming Wang, founder of Alphabet Health LTD and an expert in molecular oncology, pharmaceutical strategy, and medical education. Building on our previous discussion, we explore cutting-edge advancements in cancer diagnostics and therapies, including the promise and limitations of liquid biopsies, the evolution of immunotherapy, and the expanding role of CAR-T and antibody-drug conjugates.But innovation alone isn’t enough—how do we ensure these breakthroughs reach the patients who need them most? We tackle the challenges of healthcare communication, provider education, and patient access, examining how AI, public health initiatives, and systemic change can bridge the gap between scientific progress and real-world impact.Join hosts Dr. Na-Ri Oh and Ian Wendt for an engaging and thought-provoking conversation that not only highlights the science behind cancer treatment but also the urgent need to make these life-saving therapies more widely accessible. Don't miss this critical discussion on the future of oncology!

Bridging the Gap in Cancer Care Part1: Dr. Yaming Wang on Innovation, Access, and the Power of Knowledge

🎙 RealPharma Podcast – Oncology Part 1: Understanding the Cancer Universe with Dr. Yaming WangCancer is one of the most complex and pressing challenges in modern medicine. But how much do we really understand about it? In this first episode of our two-part oncology deep dive, we sit down with Dr. Yaming Wang, founder of Alphabet Health, to break down the fundamentals of oncology and hematology.From the earliest discoveries in cancer research to today’s cutting-edge targeted therapies and immunotherapy, Dr. Wang shares his expertise on the science behind cancer, why it remains such a difficult disease to treat, and the role of communication in bridging the gap between innovation and patient care.🔬 Topics we cover in this episode:✔ The difference between solid tumors and blood cancers✔ Why cancer is like its own universe in medicine✔ How early detection and screening can make a difference✔ The evolution of chemotherapy, targeted therapies, and immunotherapy✔ Why science alone isn’t enough—effective communication is keyWhether you're a biotech professional, healthcare communicator, or just curious about the latest in oncology, this episode is packed with insights you won’t want to miss.Resources:Dr. Yaming Wang on LinkedInAlphabet Health LTDGeneral Cancer Information & Education:🔹 National Cancer Institute (NCI) – Comprehensive cancer research and education👉 https://www.cancer.gov🔹 American Cancer Society (ACS) – Trusted resource for cancer prevention, diagnosis, and treatment👉 https://www.cancer.org🔹 World Health Organization (WHO) – Cancer Fact Sheet – Global insights on cancer trends and impact👉 https://www.who.int/news-room/fact-sheets/detail/cancerOncology Research & Innovations:🔹 American Society of Clinical Oncology (ASCO) – Latest breakthroughs in cancer treatment and clinical trials👉 https://www.asco.org🔹 National Comprehensive Cancer Network (NCCN) – Guidelines for cancer treatment and best practices👉 https://www.nccn.org🔹 ClinicalTrials.gov – Find ongoing cancer clinical trials worldwide👉 https://clinicaltrials.govCancer Screening & Prevention:🔹 CDC Cancer Prevention & Screening Guidelines – Know the recommended screening tests👉 https://www.cdc.gov/cancer/dcpc/prevention/index.htm🔹 Prevent Cancer Foundation – Focus on early detection and prevention strategies👉 https://www.preventcancer.orgEmerging Technologies & Future of Cancer Care:🔹 Caris Life Sciences – Liquid Biopsy & Precision Oncology👉 https://www.carislifesciences.com🔹 National Cancer Institute – Immunotherapy Research👉 https://www.cancer.gov/research/areas/treatment/immunotherapy🔹 AI in Oncology: How Artificial Intelligence is Changing Cancer Detection (Article from Nature)👉 https://www.nature.com/articles/d41586-020-00847-2#RealPharmaPodcast #Oncology #CancerResearch #Biotech #Pharma #MedicalInnovation #Immunotherapy #Healthcare

The Future of Healing: Stem Cells, Regenerative Medicine & What’s Next

In this episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt engage with Joshua Kettner, co-founder of DreamBody Clinic, to explore the intricacies of stem cell therapy.They discuss the clinic's unique approach to regenerative medicine, the science behind mesenchymal stem cells, and the various applications and limitations of this therapy. The conversation also delves into the regulatory challenges faced in the US and how these impact the availability of such treatments. Kettner shares personal anecdotes and insights from his experience in the field, providing a comprehensive overview of the current landscape of stem cell therapy.In this conversation, Joshua Ketner discusses the complexities of stem cell therapy, including FDA regulations, economic challenges, and the importance of donor vetting. He highlights the risks and efficacy of treatments, the growing interest in longevity and anti-aging, and the vision behind his clinic's approach to regenerative medicine. The discussion emphasizes the need for better accessibility to these treatments for patients in need.Resources:Deam Body ClinicThe Ultimate Guide to Stem Cell TherapyStem Cell Research Learning CenterStem cells: What they are and what they do

Psychedelic Renaissance: Insights from Ethnopharmacologist Dennis McKenna

In this riveting episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with the renowned ethnopharmacologist, Dennis McKenna, to explore the profound intersection of nature, science, and healing. From Dennis’s storied journey into the world of plant medicines to the evolving landscape of psychedelic therapies, this conversation is as thought-provoking as it is inspiring.Key Topics Discussed: 🌿 Dennis’s Journey: How an early fascination with psychedelics and traditional practices shaped his career in ethnopharmacology. 🌌 Modern Psychedelic Science: The exciting potential of compounds like Ibogaine and psilocybin for treating addiction, PTSD, and neurodegenerative disorders. 🌍 Ethical Dimensions: The importance of honoring indigenous knowledge and the call for reciprocity in drug development. 🔬 Challenges in Biopharma: Why current regulatory frameworks struggle with psychedelics and how innovation can bridge the gap. 🎤 McKenna Academy's Mission: Insights into biodiversity preservation, education, and the Academy’s role in advancing plant medicine research.Notable Moments:Dennis recounts the inspiration behind his 50-year journey in ethnopharmacology.A deep dive into the “set and setting” principle and its importance for both traditional and modern psychedelic practices.Discussion on how biopharma can balance commercialization with ethical responsibilities toward indigenous communities.Insights into the upcoming COCA Summit and its aim to shift perceptions and regulations around this misunderstood plant.Resources:Dennis McKenna on LinkedInDennis McKenna on WikipediaMcKenna Academy of Natural PhilosophyWisdom of the Leaf Coca SummitDennis McKenna booksLykos path to MDMA approval

Unlocking Pharma Career Success in 2025: Insights from Kristiaan Rawlings

Year-End Wrap-Up with Kristiaan RawlingsIn this episode of the Real Pharma Podcast, hosts Ian Wendt and Na-Ri Oh welcome back frequent guest Kristiaan Rawlings, a seasoned commercial pharmaceutical recruiter, for a year-end reflection on the pharmaceutical job market in 2024 and a look ahead to 2025. The discussion highlights key trends, challenges, and opportunities for candidates and employers alike.Key Highlights:Job Market TrendsExecutive PresenceHot Therapeutic AreasAdvice for CandidatesEmployer InsightsLooking to 2025Resources:Kristiaan Rawlings on LinkedInEPM ScientificBiospace: Top 12 Companies Hiring in Biopharma

Jason Scharf Explains How the Bio-Innovation Tech Stack Is Changing Everything

In this episode of the Real Pharma Podcast, hosts Ian Wendt and Dr. Na-Ri Oh and guest Jason Scharf delve into the evolving landscape of TechBio, exploring its definition, the rise of bio innovation, and the challenges and opportunities it presents.They discuss the shift from traditional drug development methods to innovative approaches driven by technology, the importance of adapting business models in the pharmaceutical industry, and the need for a balanced regulatory framework that fosters innovation while ensuring safety.Jason shares insights on the future of drug development, the role of big pharma, and the necessity for a collaborative ecosystem to drive progress in healthcare. In this conversation, Jason Scharf discusses the evolving landscape of the TechBio sector, particularly in Austin, Texas. He highlights the intersection of science and policy, the growth of Austin as a tech bio hub, and the dynamics of the local ecosystem. Scharf emphasizes the importance of innovation, investment philosophy, and the future trends shaping the industry.He also shares personal insights on entrepreneurship and the significance of understanding one's skills and passions in driving change.Resources:Jason Scharf on LinkedInJason Scharf on X (Twitter)Austin Next Podcast

Radiopharmaceuticals: The Future of Precision Medicine with Roger Estafanos

In this conversation, Roger Estafanos discusses the evolving field of radiopharmaceuticals, highlighting their transformative impact on cancer treatment and patient care.He explains the targeted nature of these therapies, the importance of personalized medicine, and the challenges faced in regulatory processes and patient safety. The discussion also covers the role of different radioisotopes, the complexities of supply chain management, and the need for improved access to these innovative treatments.The conversation delves into the complexities and advancements in the field of radiopharmaceuticals, focusing on logistics, future opportunities, investment landscapes, commercialization challenges, talent acquisition, and technological innovations. The speakers emphasize the importance of optimizing supply chains, the potential for expanding applications beyond oncology, and the role of AI in enhancing imaging processes.They also discuss the need for education among healthcare providers and patients, as well as the personal motivations driving their work in this evolving field.Resources:Roger Estafanos on LinkedIn**Society of Nuclear Medicine and Molecular Imaging (SNMMI)**  Comprehensive resource on the use of radiopharmaceuticals in imaging and therapy: [https://www.snmmi.org]**Theragnostics Explained**  An introduction to theragnostic approaches combining diagnostics and therapy: [https://www.cancer.gov/about-cancer/treatment/types/theragnostic]**U.S. Nuclear Regulatory Commission (NRC)**  Guidelines for handling, licensing, and safe administration of radiopharmaceuticals: [https://www.nrc.gov]**FDA Guidance on Radiopharmaceuticals**  Regulatory pathways and guidelines for the development of radiopharmaceuticals: [https://www.fda.gov]**Patient Advocacy in Radiopharmaceuticals**  Information for patients and caregivers about radiopharmaceutical therapies: [https://www.patientadvocate.org]**Radiopharmaceutical Treatment Education**  Tips and safety guidelines for patients undergoing radiopharmaceutical treatments: [https://www.cancer.net]**AI in Radiopharmaceutical Imaging**  How AI is transforming diagnostic imaging and patient care: [https://www.auntminnie.com]**Global Radiopharmaceutical Market Reports**  Market trends, forecasts, and analysis: [https://www.globenewswire.com]

Decoding Digital Marketing: Insights from Aaron Burnett

In this conversation, Aaron Burnett, from Wheelhouse DMG, discusses the rapid evolution of digital marketing in the healthcare sector, emphasizing the importance of data strategy and compliance with regulations like HIPAA.He highlights the shift from third-party data reliance to first-party data utilization, which enhances marketing effectiveness and patient engagement.The discussion also covers the need for collaboration among marketing, compliance, and IT teams to develop effective data strategies and the role of customer data platforms in personalizing healthcare marketing efforts.In this conversation, the speakers delve into the complexities of data privacy, patient consent, and the ethical implications of using AI in healthcare. They discuss the transformative role of AI and machine learning in digital health, emphasizing the importance of first-party data and the need for compelling content.The conversation also touches on marketing strategies in a digital landscape, the evolution of media mix modeling, and the tools that enhance digital marketing efforts. Finally, the discussion concludes with an inspiring anecdote about unconventional thinking and the pursuit of personal fulfillment.Resources:Aaron Burnett on LinkedInWheelhouse DMGDigital Marketing 2024: The Complete Guide For Beginners

AI Recap - Andree Bates Episode Review

In this latest episode of RealPharma, we’re diving back into the fascinating world of AI in pharma, breaking down all the insights from our conversation with the brilliant Andree Bates! If you missed it or want to catch the highlights, this episode serves up a concise, punchy summary covering everything from predictive analytics to patient outcomes and beyond.But there's a twist.Our hosts, this time, bring a unique, fresh perspective to the conversation—you might notice something different about how they tackle the topic. Stick around until the end, and you’ll find out what makes this episode truly special.Curious? You won’t want to miss this one. Tune in, share your thoughts, and see if you can guess what’s up! ResourcesAndree Bates on LinkedInEularisAI in biopharma research: A time to focus and scaleAI in Biopharma: Use Cases and ConsiderationsArtificial intelligence and its expanding role across the biopharma landscape